Early versus late response to PD-1-based immunotherapy in metastatic melanoma

Background - Immune checkpoint inhibition (ICI) currently is the most effective treatment to induce durable responses in metastatic melanoma. The aims of this study are the characterization of patients with early, late and non-response to ICI and analysis of survival outcomes in a real-world patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lodde, Georg Christian (VerfasserIn) , Zhao, Fang (VerfasserIn) , Herbst, Rudolf (VerfasserIn) , Terheyden, Patrick (VerfasserIn) , Utikal, Jochen (VerfasserIn) , Pföhler, Claudia (VerfasserIn) , Ulrich, Jens (VerfasserIn) , Kreuter, Alexander (VerfasserIn) , Mohr, Peter (VerfasserIn) , Gutzmer, Ralf (VerfasserIn) , Meier, Friedegund (VerfasserIn) , Dippel, Edgar (VerfasserIn) , Weichenthal, Michael (VerfasserIn) , Jansen, Philipp (VerfasserIn) , Kowall, Bernd (VerfasserIn) , Galetzka, Wolfgang (VerfasserIn) , Hörst, Fabian (VerfasserIn) , Kleesiek, Jens Philipp (VerfasserIn) , Hellwig, Birte (VerfasserIn) , Rahnenführer, Jörg (VerfasserIn) , Rajcsanyi, Luisa (VerfasserIn) , Peters, Triinu (VerfasserIn) , Hinney, Anke (VerfasserIn) , Placke, Jan-Malte (VerfasserIn) , Sucker, Antje (VerfasserIn) , Paschen, Annette (VerfasserIn) , Becker, Jürgen C. (VerfasserIn) , Livingstone, Elisabeth (VerfasserIn) , Zimmer, Lisa (VerfasserIn) , Tasdogan, Alpaslan (VerfasserIn) , Roesch, Alexander (VerfasserIn) , Hadaschik, Eva (VerfasserIn) , Schadendorf, Dirk (VerfasserIn) , Griewank, Klaus (VerfasserIn) , Ugurel, Selma (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: October 2024
In: European journal of cancer
Year: 2024, Jahrgang: 210, Pages: 1-10
ISSN:1879-0852
DOI:10.1016/j.ejca.2024.114295
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejca.2024.114295
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804924009511
Volltext
Verfasserangaben:Georg C. Lodde, Fang Zhao, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Claudia Pföhler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Michael Weichenthal, Philipp Jansen, Bernd Kowall, Wolfgang Galetzka, Fabian Hörst, Jens Kleesiek, Birte Hellwig, Jörg Rahnenführer, Luisa Rajcsanyi, Triinu Peters, Anke Hinney, Jan-Malte Placke, Antje Sucker, Annette Paschen, Jürgen C. Becker, Elisabeth Livingstone, Lisa Zimmer, Alpaslan Tasdogan, Alexander Roesch, Eva Hadaschik, Dirk Schadendorf, Klaus Griewank, Selma Ugurel

MARC

LEADER 00000caa a2200000 c 4500
001 1909083046
003 DE-627
005 20251111093757.0
007 cr uuu---uuuuu
008 241120s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2024.114295  |2 doi 
035 |a (DE-627)1909083046 
035 |a (DE-599)KXP1909083046 
035 |a (OCoLC)1475647842 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lodde, Georg Christian  |d 1992-  |e VerfasserIn  |0 (DE-588)1136630597  |0 (DE-627)89350257X  |0 (DE-576)490717403  |4 aut 
245 1 0 |a Early versus late response to PD-1-based immunotherapy in metastatic melanoma  |c Georg C. Lodde, Fang Zhao, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Claudia Pföhler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Michael Weichenthal, Philipp Jansen, Bernd Kowall, Wolfgang Galetzka, Fabian Hörst, Jens Kleesiek, Birte Hellwig, Jörg Rahnenführer, Luisa Rajcsanyi, Triinu Peters, Anke Hinney, Jan-Malte Placke, Antje Sucker, Annette Paschen, Jürgen C. Becker, Elisabeth Livingstone, Lisa Zimmer, Alpaslan Tasdogan, Alexander Roesch, Eva Hadaschik, Dirk Schadendorf, Klaus Griewank, Selma Ugurel 
264 1 |c October 2024 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 23. August 2024, Artikelversion: 29. August 2024 
500 |a Gesehen am 20.11.2024 
520 |a Background - Immune checkpoint inhibition (ICI) currently is the most effective treatment to induce durable responses in metastatic melanoma. The aims of this study are the characterization of patients with early, late and non-response to ICI and analysis of survival outcomes in a real-world patient cohort. - Methods - Patients who received PD-1-based immunotherapy for non-resectable stage-IV melanoma in any therapy line were selected from the prospective multicenter real-world DeCOG study ADOREG-TRIM (NCT05750511). Patients showing complete (CR) or partial (PR) response already during the first 3 months of treatment (Early Responders, EarlyR) were compared to patients showing CR/PR at a later time (Late Responders, LateR), a stable disease (SD) and to patients showing progressive disease (Non-Responders, NonR). - Results - Of 522 patients, 8.2 % were EarlyR (n = 43), 19.0 % were LateR (n = 99), 37.0 % had a SD (n = 193) and 35.8 % were NonR (n = 187). EarlyR, LateR and SD patients had comparable baseline characteristics. Multivariate logbinomial regression analyses adjusted for age and sex revealed positive tumor PD-L1 (RR=1.99, 95 %-CI=1.14-3.46, p = 0.015), and normal serum CRP (RR=1.59, 95 %-CI=0.93-2.70, p = 0.036) as independently associated with the achievement of an early response compared to NonR. The median progression-free and overall survival was 46.0 months (95 % CI 19.1; NR) and 47.8 months (95 %-CI 36.9; NR) for EarlyR, NR (95 %-CI NR; NR) for LateR, 8.1 months (7.0; 10.4) and 35.4 months (29.2; NR) for SD, and 2.0 months (95 %-CI 1.9; 2.1) and 6.1 months (95 %-CI 4.6; 8.8) for NonR patients. - Conclusion - Less than 10 % of metastatic melanoma patients achieved an early response during the first 3 months of PD-1-based immunotherapy. Early responders were not superior to late responders in terms of response durability and survival. 
650 4 |a Best overall response 
650 4 |a CTLA-4 
650 4 |a Immune checkpoint inhibition 
650 4 |a Immunotherapy 
650 4 |a Melanoma 
650 4 |a PD-1 
650 4 |a PD-L1 
650 4 |a Survival 
650 4 |a Therapy outcome 
700 1 |a Zhao, Fang  |e VerfasserIn  |4 aut 
700 1 |a Herbst, Rudolf  |e VerfasserIn  |4 aut 
700 1 |a Terheyden, Patrick  |e VerfasserIn  |4 aut 
700 1 |a Utikal, Jochen  |d 1974-  |e VerfasserIn  |0 (DE-588)1026463750  |0 (DE-627)726765015  |0 (DE-576)371816580  |4 aut 
700 1 |a Pföhler, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Ulrich, Jens  |e VerfasserIn  |4 aut 
700 1 |a Kreuter, Alexander  |d 1971-  |e VerfasserIn  |0 (DE-588)132383993  |0 (DE-627)521950546  |0 (DE-576)299112063  |4 aut 
700 1 |a Mohr, Peter  |e VerfasserIn  |4 aut 
700 1 |a Gutzmer, Ralf  |d 1968-  |e VerfasserIn  |0 (DE-588)113713371  |0 (DE-627)502213558  |0 (DE-576)289772095  |4 aut 
700 1 |a Meier, Friedegund  |e VerfasserIn  |4 aut 
700 1 |a Dippel, Edgar  |e VerfasserIn  |0 (DE-588)1076191460  |0 (DE-627)834540207  |0 (DE-576)171696824  |4 aut 
700 1 |a Weichenthal, Michael  |e VerfasserIn  |0 (DE-588)140953272  |0 (DE-627)623003848  |0 (DE-576)321514157  |4 aut 
700 1 |a Jansen, Philipp  |e VerfasserIn  |4 aut 
700 1 |a Kowall, Bernd  |e VerfasserIn  |4 aut 
700 1 |a Galetzka, Wolfgang  |e VerfasserIn  |4 aut 
700 1 |a Hörst, Fabian  |e VerfasserIn  |4 aut 
700 1 |a Kleesiek, Jens Philipp  |d 1977-  |e VerfasserIn  |0 (DE-588)132998076  |0 (DE-627)530080745  |0 (DE-576)299554465  |4 aut 
700 1 |a Hellwig, Birte  |e VerfasserIn  |4 aut 
700 1 |a Rahnenführer, Jörg  |e VerfasserIn  |4 aut 
700 1 |a Rajcsanyi, Luisa  |e VerfasserIn  |4 aut 
700 1 |a Peters, Triinu  |e VerfasserIn  |4 aut 
700 1 |a Hinney, Anke  |e VerfasserIn  |4 aut 
700 1 |a Placke, Jan-Malte  |e VerfasserIn  |0 (DE-588)1131806557  |0 (DE-627)886545293  |0 (DE-576)488493978  |4 aut 
700 1 |a Sucker, Antje  |e VerfasserIn  |4 aut 
700 1 |a Paschen, Annette  |e VerfasserIn  |0 (DE-588)1076261353  |0 (DE-627)834584263  |0 (DE-576)445109475  |4 aut 
700 1 |a Becker, Jürgen C.  |e VerfasserIn  |4 aut 
700 1 |a Livingstone, Elisabeth  |e VerfasserIn  |0 (DE-588)1049231325  |0 (DE-627)781379636  |0 (DE-576)403194016  |4 aut 
700 1 |a Zimmer, Lisa  |e VerfasserIn  |4 aut 
700 1 |a Tasdogan, Alpaslan  |e VerfasserIn  |4 aut 
700 1 |a Roesch, Alexander  |d 1805-1851  |e VerfasserIn  |0 (DE-588)1227921047  |0 (DE-627)1749125625  |4 aut 
700 1 |a Hadaschik, Eva  |e VerfasserIn  |0 (DE-588)1054876916  |0 (DE-627)792376684  |0 (DE-576)410969842  |4 aut 
700 1 |a Schadendorf, Dirk  |d 1960-  |e VerfasserIn  |0 (DE-588)11142576X  |0 (DE-627)499566076  |0 (DE-576)289702275  |4 aut 
700 1 |a Griewank, Klaus  |d 1978-  |e VerfasserIn  |0 (DE-588)133004112  |0 (DE-627)53008497X  |0 (DE-576)299558223  |4 aut 
700 1 |a Ugurel, Selma  |d 1971-  |e VerfasserIn  |0 (DE-588)122030923  |0 (DE-627)081693532  |0 (DE-576)293057567  |4 aut 
773 0 8 |i Enthalten in  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 210(2024), Artikel-ID 114295, Seite 1-10  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a Early versus late response to PD-1-based immunotherapy in metastatic melanoma 
773 1 8 |g volume:210  |g year:2024  |g elocationid:114295  |g pages:1-10  |g extent:10  |a Early versus late response to PD-1-based immunotherapy in metastatic melanoma 
856 4 0 |u https://doi.org/10.1016/j.ejca.2024.114295  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0959804924009511  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241120 
993 |a Article 
994 |a 2024 
998 |g 122030923  |a Ugurel, Selma  |m 122030923:Ugurel, Selma  |d 60000  |e 60000PU122030923  |k 0/60000/  |p 35  |y j 
998 |g 11142576X  |a Schadendorf, Dirk  |m 11142576X:Schadendorf, Dirk  |d 50000  |e 50000PS11142576X  |k 0/50000/  |p 33 
998 |g 1054876916  |a Hadaschik, Eva  |m 1054876916:Hadaschik, Eva  |d 910000  |d 911300  |e 910000PH1054876916  |e 911300PH1054876916  |k 0/910000/  |k 1/910000/911300/  |p 32 
998 |g 1076261353  |a Paschen, Annette  |m 1076261353:Paschen, Annette  |d 50000  |e 50000PP1076261353  |k 0/50000/  |p 26 
998 |g 132998076  |a Kleesiek, Jens Philipp  |m 132998076:Kleesiek, Jens Philipp  |d 50000  |e 50000PK132998076  |k 0/50000/  |p 18 
998 |g 1026463750  |a Utikal, Jochen  |m 1026463750:Utikal, Jochen  |d 60000  |e 60000PU1026463750  |k 0/60000/  |p 5 
999 |a KXP-PPN1909083046  |e 4617057234 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"disp":"Early versus late response to PD-1-based immunotherapy in metastatic melanomaEuropean journal of cancer","recId":"266883400","pubHistory":["28.1992 -"],"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"corporate":[{"role":"isb","display":"European Organization for Research on Treatment of Cancer"},{"role":"isb","display":"European Association for Cancer Research"},{"role":"isb","display":"European School of Oncology"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1879-0852"],"zdb":["1468190-0"],"eki":["266883400"]},"origin":[{"dateIssuedKey":"1992","publisher":"Elsevier ; Pergamon Press","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1992-"}],"part":{"volume":"210","year":"2024","extent":"10","pages":"1-10","text":"210(2024), Artikel-ID 114295, Seite 1-10"},"titleAlt":[{"title":"EJC online"}],"title":[{"title":"European journal of cancer","title_sort":"European journal of cancer"}]}],"physDesc":[{"extent":"10 S."}],"person":[{"role":"aut","given":"Georg Christian","family":"Lodde","display":"Lodde, Georg Christian"},{"family":"Zhao","display":"Zhao, Fang","given":"Fang","role":"aut"},{"role":"aut","display":"Herbst, Rudolf","family":"Herbst","given":"Rudolf"},{"role":"aut","display":"Terheyden, Patrick","family":"Terheyden","given":"Patrick"},{"family":"Utikal","display":"Utikal, Jochen","given":"Jochen","role":"aut"},{"family":"Pföhler","display":"Pföhler, Claudia","given":"Claudia","role":"aut"},{"role":"aut","display":"Ulrich, Jens","family":"Ulrich","given":"Jens"},{"given":"Alexander","display":"Kreuter, Alexander","family":"Kreuter","role":"aut"},{"role":"aut","given":"Peter","display":"Mohr, Peter","family":"Mohr"},{"role":"aut","family":"Gutzmer","display":"Gutzmer, Ralf","given":"Ralf"},{"family":"Meier","display":"Meier, Friedegund","given":"Friedegund","role":"aut"},{"given":"Edgar","family":"Dippel","display":"Dippel, Edgar","role":"aut"},{"role":"aut","given":"Michael","family":"Weichenthal","display":"Weichenthal, Michael"},{"role":"aut","family":"Jansen","display":"Jansen, Philipp","given":"Philipp"},{"display":"Kowall, Bernd","family":"Kowall","given":"Bernd","role":"aut"},{"given":"Wolfgang","family":"Galetzka","display":"Galetzka, Wolfgang","role":"aut"},{"family":"Hörst","display":"Hörst, Fabian","given":"Fabian","role":"aut"},{"given":"Jens Philipp","family":"Kleesiek","display":"Kleesiek, Jens Philipp","role":"aut"},{"given":"Birte","display":"Hellwig, Birte","family":"Hellwig","role":"aut"},{"role":"aut","given":"Jörg","family":"Rahnenführer","display":"Rahnenführer, Jörg"},{"family":"Rajcsanyi","display":"Rajcsanyi, Luisa","given":"Luisa","role":"aut"},{"family":"Peters","display":"Peters, Triinu","given":"Triinu","role":"aut"},{"role":"aut","family":"Hinney","display":"Hinney, Anke","given":"Anke"},{"given":"Jan-Malte","display":"Placke, Jan-Malte","family":"Placke","role":"aut"},{"role":"aut","given":"Antje","display":"Sucker, Antje","family":"Sucker"},{"role":"aut","family":"Paschen","display":"Paschen, Annette","given":"Annette"},{"role":"aut","given":"Jürgen C.","display":"Becker, Jürgen C.","family":"Becker"},{"role":"aut","family":"Livingstone","display":"Livingstone, Elisabeth","given":"Elisabeth"},{"role":"aut","display":"Zimmer, Lisa","family":"Zimmer","given":"Lisa"},{"given":"Alpaslan","family":"Tasdogan","display":"Tasdogan, Alpaslan","role":"aut"},{"role":"aut","display":"Roesch, Alexander","family":"Roesch","given":"Alexander"},{"given":"Eva","display":"Hadaschik, Eva","family":"Hadaschik","role":"aut"},{"role":"aut","given":"Dirk","family":"Schadendorf","display":"Schadendorf, Dirk"},{"given":"Klaus","family":"Griewank","display":"Griewank, Klaus","role":"aut"},{"role":"aut","given":"Selma","family":"Ugurel","display":"Ugurel, Selma"}],"title":[{"title":"Early versus late response to PD-1-based immunotherapy in metastatic melanoma","title_sort":"Early versus late response to PD-1-based immunotherapy in metastatic melanoma"}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"October 2024"}],"id":{"doi":["10.1016/j.ejca.2024.114295"],"eki":["1909083046"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1909083046","note":["Online verfügbar: 23. August 2024, Artikelversion: 29. August 2024","Gesehen am 20.11.2024"],"name":{"displayForm":["Georg C. Lodde, Fang Zhao, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Claudia Pföhler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Michael Weichenthal, Philipp Jansen, Bernd Kowall, Wolfgang Galetzka, Fabian Hörst, Jens Kleesiek, Birte Hellwig, Jörg Rahnenführer, Luisa Rajcsanyi, Triinu Peters, Anke Hinney, Jan-Malte Placke, Antje Sucker, Annette Paschen, Jürgen C. Becker, Elisabeth Livingstone, Lisa Zimmer, Alpaslan Tasdogan, Alexander Roesch, Eva Hadaschik, Dirk Schadendorf, Klaus Griewank, Selma Ugurel"]}} 
SRT |a LODDEGEORGEARLYVERSU2024